Login to Your Account



Orphan Medical Cataplexy Drug Xyrem Approved By FDA

By Karen Young


Friday, July 19, 2002
Nearly two years after the company filed its new drug application, Orphan Medical Inc. said after the markets closed Wednesday it won FDA approval for Xyrem, designed to treat cataplexy associated with narcolepsy. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription